Search - tctmd.com

Displaying 81 - 100 of 558

Sort: Relevancy | Date

Presentation TCT 2023

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

Presenter: Hamza Naveed

October 25, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Presentation TCT 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presenter: Victor Zeijen

October 25, 2023

Presentation TCT 2023

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

Presenter: Karl Fengler

October 25, 2023

Presentation TCT 2023

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Presenter: Anna Subbotina

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Clinician Perspectives

Presenter: Naomi Fisher

October 24, 2023

Presentation TCT 2023

Industry Perspectives

Presenter: Sandeep Brar

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions

Presenter: Andrew Sharp

October 23, 2023

Presentation TCT 2023

The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective

Presenter: Dana Asato

October 23, 2023

Presentation TCT 2023

Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies

Presenter: Peter Monteleone

October 23, 2023

Presentation TCT 2023

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Presenter: Kimberly Ferlin

October 23, 2023

Presentation TCT 2023

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Presenter: Natalie Miller

October 23, 2023

Presentation TCT 2023

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Presenter: Girish Kumar

October 23, 2023

Presentation TCT 2023

Special Considerations in Conducting an Early Feasibility/First-in-Human Study in the US: From Bench to Bedside

Presenter: Changfu Wu

October 23, 2023

Presentation TCT 2023

Achieving the IDE Approval Milestone: Tips and Common Deficiencies to Avoid

Presenter: Jaime Raben

October 23, 2023

Presentation TCT 2023

Optimizing the Q-Submissions Including the Breakthrough Device Designation Requests: Do's and Don’ts

Presenter: Jennifer Bastijanic

October 23, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

Advertisement

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Clinician Perspectives

Industry Perspectives

Trialist Perspectives

Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions

The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective

Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Special Considerations in Conducting an Early Feasibility/First-in-Human Study in the US: From Bench to Bedside

Achieving the IDE Approval Milestone: Tips and Common Deficiencies to Avoid

Optimizing the Q-Submissions Including the Breakthrough Device Designation Requests: Do's and Don’ts

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content